Folic acid mediated attenuation of loss of heterozygosity of DCC tumor suppressor gene in the colonic mucosa of patients with colorectal adenomas

By Nagothu K.K.   Jaszewski R.   Moragoda L.   Rishi A.K.   Finkenauer R.   Tobi M.   Naumoff J.A.   Dhar R.   Ehrinpreis M.   Kucuk O.   Majumdar A.P.N.  

Cancer Detection and Prevention, Vol. 27, Iss. 4, 2003-01 ,pp. : 297-304

Elsevier

Access to resources Recommend Favorite

Loss of Heterozygosity at the 9p21-24 Region and Identification of BRM as a Candidate Tumor Suppressor Gene in Head and Neck Squamous Cell Carcinoma

By Gunduz Esra   Gunduz Mehmet   Ali Mahmoud Al Sheik   Beder Levent   Tamamura Ryo   Katase Naoki   Tominaga Susumu   Yamanaka Noboru   Shimizu Kenji   Nagatsuka Hitoshi  

Cancer Investigation, Vol. 27, Iss. 6, 2009-07 ,pp. : 661-668

Informa Healthcare

Access to resources Recommend Favorite

SIRT3: Oncogene and Tumor Suppressor in Cancer

By Torrens-Mas Margalida   Oliver Jordi   Roca Pilar   Sastre-Serra Jorge  

Cancers, Vol. 9, Iss. 7, 2017-07 ,pp. : 90-90

MDPI

Access to resources Recommend Favorite

Effect of tumor suppressor gene cyclindependent kinase inhibitor 2A wildtype and A148T mutant on the cell cycle of human ovarian cancer cells

By            

Oncology Letters, Vol. 7, Iss. 4, 2014-01 ,pp. : 1229-1232

Spandidos Publications

Access to resources Recommend Favorite

Role of DLC1 tumor suppressor gene and MYC oncogene in pathogenesis of human hepatocellular carcinoma: Potential prospects for combined targeted therapeutics (Review)

By    

International Journal of Oncology, Vol. 41, Iss. 2, 2012-01 ,pp. : 393-406

Spandidos Publications

Access to resources Recommend Favorite